RETRACTED ARTICLE: Optical imaging medical diagnosis and analysis of drug treatment for endometriosis and the impact of serum VEGF and MMP-9

With the continuous development of biomedical imaging technologies such as computed tomography, laser scanning confocal microscopy and ultrasonic imaging, biomedical imaging plays an increasingly obvious role in this field and becomes an important means of biological research and clinical medicine diagnosis and treatment. The purpose of the study was to analyze the application of optical imaging in the medical diagnosis of endometriosis, and to explore the effect of drug therapy on the disease. The changes in serum VEGF and MMP-9 levels in endometriosis and their potential clinical significance were also investigated. This study mainly analyzes and compares the efficacy of Sanjie Zhentong capsule combined with norethisterone tablets in the treatment of endometriosis and the effect on serum VEGF, MMP-9 and sICAM-1 levels. The total effective rate of patients in group B after this combined intervention was 91.07% (51/56), which was more significant compared with 75.0% (39/52) of patients in group A. The curative effect of the included patients in the two groups was significant. After intervention, the VEGF (193.62 ± 45.45), MMP-9 (197.34 ± 22.63), and sICAM-1 (323.58 ± 8.52) indexes of patients in group A were compared with those of patients in group B (121.45 ± 34.78), MMP-9 ( 128.56 ± 15.86), sICAM-1 (264.87 ± 7.62). The results show that it has high safety and fewer clinical adverse symptoms. Through optical imaging technology, patients with endometriosis are accurately diagnosed and the extent and location of their lesions are observed, helping doctors to provide accurate diagnosis and treatment recommendations. Similar content being viewed by others Data availability The data will be available upon request. Change history 08 October 2024 This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s11082-024-07636-5

Amini, L., Shami, M., Chegini, R.: The relationship between serum levels of oxidative stress biomarkers and dysmenorrhea, dyspareunia and pelvic pain in women with endometriosis. Iran J. Nurs. 6(126), 90–92 (2020) Arumugam, K.: Serum prolactin levels in infertile patients with endometriosis. Malays. J. Pathol. 13(1), 43–45 (2021) Barcz, E., Kamiński, P., Marianowski, L.: Serum VEGF (vascular endothelial growth factor) concentration in patients with endometriosis. Ginekol. Pol. 71(9), 993–1000 (2020) Cahill, D.J., et al.: Effect of progestogen therapy on follicular development, related hormone concentrations and fertilization in vitro in unstimulated cycles and unexplained and endometriosis-associated infertility. Hum. Reprod. (Oxford, England) 65(23), 12–15 (2018) Chartier, M.: Antiovulatory drugs in the treatment of endometriosis. Netter A 32(34), 52–55 (2020) Essam, E.E.-D.R.: Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 20(21), 1–5 (2018) Ferrero, S., Gillott, D.J., Anserini, P., et al.: Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Int. J. Fertility Steril. 19(1), 220–221 (2019) Ferrero, S., Venturini, P.L., Gillott, D.J., et al.: Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial. Reprod. Biol. Endocrinol. 9(1), 88 (2021) Fu, C., Lang, J.: Serum soluble E-cadherin level in patients with endometriosis. Chin. Med. Sci. J. 17(2), 121–123 (2021) Gagne, D., Page, M., Robitaille, G., et al.: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum. Reprod. 6(67), 2–5 (2021) Gagné, D., Pagé, M., Robitaille, G., et al.: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum. Reprod. 18(8), 1674–1680 (2019) Gosselin, D., Gagné, D., Pagé, M., et al.: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum. Reprod. 60(54), 12–19 (2018) Grandi, G., Mueller, M., Bersinger, N., et al.: Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells. Am. J. Reprod. Immunol. 66(54), 152–154 (2016) Kianpour, M., Nematbakhsh, M., Ahmadi, S.M., et al.: Serum and peritoneal fluid levels of vascular endothelial growth factor in women with endometriosis. Int. J. Fertility Steril. 7(2), 96–99 (2018) Qi-Gu, L.I., Pharmacy, D.O.: Clinical study on compound norethindrone tablet combined with metformin in the treatment of polycystic ovary syndrome. Med. Recapitulate 40(43), 82–85 (2018) Ravn, P., Bergqvist, A., Hansen, M.A., et al.: Treatment of endometriosis with the luteinizing hormone-releasing hormone agonist nafarelin. Effect on bone turnover and bone mass. Menopause J. North Am. Menopause Soc. 1(1), 11–17 (2021) Sozzi, F., Morotti, M.: Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. Eur. J. Obstet. Gynecol. Reprod. Biol. Int. J. 183(44), 188–192 (2018) Taniguchi, F., Enatsu, A., Ikebuchi, A., et al.: Efficacy of norethisterone in patients with ovarian endometrioma. Yonago Acta Medica 60(3), 182–185 (2017) Yang, W.M.: Influence of mifepristone tablets on recurrence and serum VEGF of endometriosis patients after operation. J. Qiqihar Univ. Med. 4(32), 142–145 (2018) Zhang, Q., Teng, H., Yuli, H.U.: Effects of leuprolide acetate microspheres combined with laparoscopy on serum TIMP-1 MMP-9 levels and conception rate in patients with endometriosis. Hebei Med. 3(32), 184–185 (2019) Funding The authors have not disclosed any funding. Author information Authors and Affiliations Contributions CW has done the first version, QL has done the simulations. All authors have contributed to the paper’s analysis, discussion, writing, and revision. Corresponding author Ethics declarations Conflict of interest The authors declare that they have no conflict of interests. Ethical approval Not applicable. Additional information Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This article has been retracted. Please see the retraction notice for more detail:https://doi.org/10.1007/s11082-024-07636-5 Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Wang, C., Li, Q. RETRACTED ARTICLE: Optical imaging medical diagnosis and analysis of drug treatment for endometriosis and the impact of serum VEGF and MMP-9. Opt Quant Electron 56, 479 (2024). https://doi.org/10.1007/s11082-023-06159-9 Received: Accepted: Published: Version of record: DOI: https://doi.org/10.1007/s11082-023-06159-9